Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Akari Therapeutics Announces Formation of Scientific Advisory Board and Inaugural Appointment of Renowned Medical Oncologist, Sara A. Hurvitz, MD, FACP
-
Viomi Technology Co., Ltd to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on November 4, 2025
-
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
-
Worksport Announces Official Launch Date for SOLIS and COR Clean Energy Products
-
Banzai to Host Third Quarter 2025 Financial Results Conference Call on Friday, November 14, 2025 at 4:30 p.m. Eastern Time
-
SEGG Media Charts a Bold Course into Web3 with $300M Digital Asset Initiative
-
InterDigital Announces Financial Results For Third Quarter 2025
-
Red River Bancshares, Inc. Reports Third Quarter 2025 Financial Results
-
ECGI Holdings Joins Entrepreneur Ventures to Expand Institutional Deal Flow
-
Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025
-
Quoin Pharmaceuticals to Provide Corporate Update and Announce Third Quarter 2025 Financial Results on Thursday, November 6, 2025
-
Aterian Sets Date for Third Quarter 2025 Earnings Announcement & Investor Conference Call
-
Holley Performance Brands Demonstrates Strong Momentum and Product Innovation at SEMA 2025
-
Dorel Industries Will Hold a Conference Call to Discuss Its Third Quarter Results
-
MAX Power Mining Corp. (OTC: MAXXF) (CSE: MAXX) Emerging as Leader in New Frontier of Natural Hydrogen as Energy Source
-
Vivakor’s Trading Platform Launches Full-Scale Operations with $24 Million Commodity Transaction
-
JE CLEANTECH (JCSE) ANNOUNCES RESULTS FOR H1 2025
-
Alliance Entertainment Secures Exclusive U.S. Home Entertainment and Digital Rights Agreement with Eli Roth’s The Horror Section
-
Nunes Issues Statement on Secret Subpoena of Trump Media Bank Records
-
TechForce Robotics Accepted into NVIDIA Connect Program, Strengthening Position in AI-Driven Hospitality Automation
-
IperionX – September 2025 Quarterly Report
-
Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025
-
Amaze Expands Into the Metaverse Through Strategic Partnership with Dubit
-
GlobalFoundries and Silicon Labs Expand Partnership to Accelerate Wireless Connectivity Solutions and Strengthen U.S. Chip Manufacturing
-
Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
-
Aether Holdings to Showcase Cutting-Edge Sentiment Analytics at Hong Kong FinTech Week 2025
-
Capital Clean Energy Carriers Corp. Announces Third Quarter 2025 Financial Results
-
Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update
-
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting
-
Cellebrite Appoints Holly Windham as General Counsel and Chief Compliance Officer
-
Itron Announces Third Quarter 2025 Financial Results
-
Stingray Acquires DMI, Adding 8,500 Locations to its U.S. In-Store Audio Advertising Network
-
Mobile Infrastructure Closes $100 Million Asset-Backed Securitization
-
Nexalin Technology Announces Regulatory Approval to Sell Gen 2 SYNC, 15 mA Neurostimulation DIFS™ Device in Israel
-
Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480
-
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025
-
MAX Power Mining Corp. (OTC: MAXXF) (CSE: MAXX) Emerging as Leader in New Frontier of Natural Hydrogen as Energy Source
-
Oncotelic Therapeutics Inc. (OTCQB: OTLC) at Forefront of Effort to Optimize Next-Generation Cancer Therapies
-
Aterian Sets Date for Third Quarter 2025 Earnings Announcement & Investor Conference Call
-
Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution
-
Aembit Introduces Identity and Access Management for Agentic AI
-
Taylor Carr Named President of Allied Universal Technology Services
-
Bridge Investment Group Raises More than $2 Billion for Bridge Debt Strategies V
-
Inuvo to Host Third Quarter 2025 Financial Results Conference Call on Thursday, November 6th at 4:15 P.M. ET
-
Materialise to Hold Extraordinary Shareholders’ Meeting on November 14, 2025
-
Publication of Prospectus
-
Capstone Asset Management Launches Canada's First Biblically Informed ETFs on Toronto Stock Exchange
-
Freddie Mac Announces Third Quarter 2025 Financial Results
-
Hoag selects Philips to enhance and unify patient monitoring, elevating care across Orange County, USA
-
FTSE Russell and StepStone Group launch global fund-level daily private market indices

